RDT Announces FDA Clearance and US Release of Tempus IC™ Remote Vital Signs Monitor
Remote Diagnostic Technologies (RDT) Ltd., a developer of remote medical equipment for use by non-medical experts, has recently received clearance from the U.S. Food and Drug Administration (FDA) for its new compact remote vital signs monitor, the Tempus IC™.
Breaking new ground in remote vital signs monitoring, Tempus IC™ is the latest patient monitor from RDT that has been designed for ease of use, compact communications technology, minimal weight and maximum robustness. SunTech Medical, a leader in clinical grade non invasive blood pressure (NIBP) technology, has partnered with RDT to provide OEM NIBP technology for the Tempus IC™.